David N Gill's Net Worth
$6.05 Million
Who is David N Gill?
David N Gill has an estimated net worth of $6.05 Million. This is based on reported shares across multiple companies, which include ISOTIS INC, CTI MOLECULAR IMAGING INC, CEMPRA, INC., Y-mAbs Therapeutics, Inc., HISTOGENICS CORP, LEMAITRE VASCULAR INC, Evolus, Inc., Strongbridge Biopharma plc, STRATA Skin Sciences, Inc., ECPM Holdings, LLC, NxStage Medical, Inc., and IDLEAIRE TECHNOLOGIES CORP.
SEC CIK
David N Gill's CIK is 0001106519
Past Insider Trading and Trends
2018 was David N Gill's most active year for acquiring shares with 8 total transactions. David N Gill's most active month to acquire stocks was the month of May. 2004 was David N Gill's most active year for disposing of shares, totalling 8 transactions. David N Gill's most active month to dispose stocks was the month of April. 2004 saw David N Gill paying a total of $109,218.75 for 147,300 shares, this is the most they've acquired in one year. In 2005 David N Gill cashed out on 345,247 shares for a total of $1,906,500.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ISOTIS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
CTI MOLECULAR IMAGING INC No price found
Senior Vice President and CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -99.40K |
$20.50 | -$2,037,700.00 |
0
|
Apr 29 - May 5
| |||
Form 4
| +11.64% | 9.7K |
$4.69 | $45,468.75 | 93K |
Jan 18
| |||
Form 4
| +14.42% | 10.5K |
$4.69 | $49,223.44 | 83.3K |
Oct 18
| |||
Form 4
| +21.33% | 12.8K |
$4.69 | $59,995.31 | 72.8K |
Oct 14
| |||
Form 4
|
∞
| 60K |
—
|
—
| 60K |
Oct 7
| |||
Form 4
| -100.00% | -15.00K |
$13.72 | -$205,800.00 |
0
|
Jun 2
| |||
Form 4
| -40.00% | -10.00K |
$14.07 | -$140,700.00 | 15K |
May 11
| |||
Form 4
| -35.90% | -14.00K |
$16.49 | -$230,889.40 | 25K |
Mar 2
| |||
Form 4
| -29.09% | -16.00K |
$17.67 | -$282,720.00 | 39K |
Feb 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 25
| |||
Form 4
| -8.33% | -5.00K |
$15.45 | -$77,250.00 | 55K |
Dec 15
| |||
Form 4
| -24.09% | -19.04K |
$15.38 | -$292,764.00 | 60K |
Dec 10 - Dec 11
| |||
No matching records found |
CEMPRA, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
| +500.00% | 5K |
$6.09 | $30,450.00 | 6K |
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
∞
| 5K |
$2.94 | $14,720.00 | 5K |
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Y-mAbs Therapeutics, Inc. (YMAB) Snapshot price: $13.82
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +150.00% | 3.5K |
—
|
—
| 5.83K |
Jun 11
| |||
Form 4
|
∞
| 2.33K |
—
|
—
| 2.33K |
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
$28.84 | -$70,725.20 |
0
|
Scheduled
|
Jan 19
| ||
Form 4
|
—
|
0
|
$28.47 | -$69,210.00 |
0
|
Scheduled
|
Nov 18
| ||
Form 4
|
—
|
0
|
$28.08 | -$135,360.00 |
0
|
Scheduled
|
Nov 3
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
HISTOGENICS CORP (OCGN) Snapshot price: $1.13
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
| +27.27% | 3K |
$1.81 | $5,439.00 | 14K |
Aug 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
| +37.50% | 3K |
$1.68 | $5,040.00 | 11K |
May 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 16
| |||
Form 4
| +60.00% | 3K |
$1.65 | $4,950.00 | 8K |
Dec 15
| |||
Form 4
|
∞
| 5K |
$1.92 | $9,600.00 | 5K |
Dec 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |